SecBot SecBot
8-K ·Filed Jun 23, 2026

TBPH

Theravance Biopharma, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago SEC0001104659-26-076857
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine execution of a previously announced restructuring plan. No immediate trading signal. Monitor the next 10-Q for updates on the restructuring's financial impact and any further headcount reductions.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$17.27
T+0 close · Jun 23, 2026 · via day close
Latest settled
−1.33%
T+60 · $17.04
Vs SPY
−4.17%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 24 $17.27entry
  2. T+1 · 5mo ago +0.69%α +0.55% · $17.39
  3. T+5 · 5mo ago −1.68%α −3.39% · $16.98
  4. T+20 · 4mo ago −2.66%α −4.60% · $16.81
  5. T+60 · 2mo ago −1.33%α −4.17% · $17.04
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Theravance Biopharma disclosed the planned departure of SVP Development and Head of Ireland Office, Dr. ine Miller, effective November 15, 2026, under a compromise agreement tied to the restructuring announced in March 2026. The filing includes a grant of 18,750 RSUs and a $250,000 pension contribution. This is a routine, previously anticipated executive exit with no unexpected C-suite changes.

Key Facts

  • Dr. ine Miller, SVP Development and Head of Ireland Office, will terminate employment on November 15, 2026.
  • Departure is part of the restructuring announced by the company in March 2026.
  • Dr. Miller received a grant of 18,750 restricted share units on June 19, 2026.
  • The company will make a special pension contribution of $250,000 within 30 days of the termination date.
  • CEO Rick E. Winningham remains in place; no other executive changes disclosed.

Financial Impact

Total disclosed cash cost of $250,000 pension contribution plus 18,750 RSUs; immaterial relative to $854M market cap.

cashshare count (dilution from RSUs)

Risk Factors

  • Restructuring may signal ongoing operational challenges or cost pressures.
  • Further executive departures could indicate deeper organizational issues.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-076857
Document: 0001104659-26-076857-index-headers.html0001104659-26-076857
Document: 0001104659-26-076857-index.html0001104659-26-076857
Document: 0001104659-26-076857.txt0001104659-26-076857

Track record

12 reports on TBPH

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +2.11% at T+1 after the Mar 3, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 4/10 Entry price pending
  2. Oct 5, 20266w ago 15-12G Bearish 7/10 No price data
  3. Sep 25, 20267w ago SC 13D/A Neutral 4/10 Entry $17.04 No price data
  4. Sep 23, 20267w ago 25-NSE Bearish 7/10 Entry $17.05 No price data
  5. Aug 25, 202611w ago DEFA14A Neutral 4/10 Entry $17.03 to $17.03 · 0.00% −0.23% vs SPY
  6. Aug 21, 202612w ago DEFM14A Bullish 7/10 Entry $17.01 to $17.05 ▲ +0.24% +0.76% vs SPY
  7. Aug 11, 202613w ago PREM14A Bullish 7/10 Entry $16.91 to $17.06 ▲ +0.89% +1.95% vs SPY
  8. Aug 10, 202614w ago 8-K Bullish 7/10 Entry $16.91 to $17.06 ▲ +0.89% +1.80% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 7/10 Entry $17.06 to $16.86 ▼ −1.17% −0.89% vs SPY
  10. Jun 23, 202620w ago 8-K Neutral 2/10 Viewing Entry $17.27 to $16.81 ▼ −2.66% −4.60% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 8h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 23, 2026